MX2019014935A - Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos. - Google Patents

Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos.

Info

Publication number
MX2019014935A
MX2019014935A MX2019014935A MX2019014935A MX2019014935A MX 2019014935 A MX2019014935 A MX 2019014935A MX 2019014935 A MX2019014935 A MX 2019014935A MX 2019014935 A MX2019014935 A MX 2019014935A MX 2019014935 A MX2019014935 A MX 2019014935A
Authority
MX
Mexico
Prior art keywords
muscarinic antagonists
horses
treatment
airway disease
combinations
Prior art date
Application number
MX2019014935A
Other languages
English (en)
Inventor
Aven Michael
Albrecht Balazs
Lamar Janine
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of MX2019014935A publication Critical patent/MX2019014935A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
    • A61K35/06—Mineral oils, e.g. paraffinic oils or aromatic oils based on aromatic hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2250/00—Specially adapted for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere al campo de la medicina, en particular al campo de la medicina veterinaria. La invención se refiere, específicamente, a antagonistas muscarínicos (incluyendo antagonistas muscarínicos de larga acción (LAMAs) para el tratamiento de enfermedades de las vías respiratorias tales como la enfermedad pulmonar, preferiblemente la obstrucción recurrente de las vías respiratorias (RAO), enfermedad pulmonar obstructiva asociada al pasto del verano (SPAOPD) y la enfermedad inflamatoria de las vías respiratorias (IAD) en animales, preferiblemente equinos tales como caballos.
MX2019014935A 2014-06-18 2016-12-15 Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos. MX2019014935A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14172925 2014-06-18

Publications (1)

Publication Number Publication Date
MX2019014935A true MX2019014935A (es) 2020-02-13

Family

ID=50972546

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016016720A MX370430B (es) 2014-06-18 2015-06-15 Antagonistas muscarínicos y sus combinaciones para el tratamiento de enfermedades de las vías respiratorias en caballos.
MX2019014935A MX2019014935A (es) 2014-06-18 2016-12-15 Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2016016720A MX370430B (es) 2014-06-18 2015-06-15 Antagonistas muscarínicos y sus combinaciones para el tratamiento de enfermedades de las vías respiratorias en caballos.

Country Status (17)

Country Link
US (3) US9474747B2 (es)
EP (2) EP3603640A1 (es)
KR (1) KR102618119B1 (es)
AU (2) AU2015276310B2 (es)
CA (1) CA2952701C (es)
CY (1) CY1122335T1 (es)
DK (1) DK3157522T3 (es)
ES (1) ES2759247T3 (es)
HR (1) HRP20192010T1 (es)
HU (1) HUE051527T2 (es)
LT (1) LT3157522T (es)
MX (2) MX370430B (es)
PL (1) PL3157522T3 (es)
PT (1) PT3157522T (es)
RS (1) RS59613B1 (es)
SI (1) SI3157522T1 (es)
WO (1) WO2015193213A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3473255T (lt) 2012-12-21 2022-03-10 Boehringer Ingelheim Vetmedica Gmbh Farmacinė vaisto forma, apimanti ciklezonidą
WO2014096115A1 (en) 2012-12-21 2014-06-26 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for the treatment of airway disease in horses
PL3157522T3 (pl) 2014-06-18 2020-03-31 Boehringer Ingelheim Vetmedica Gmbh Antagonisty muskarynowi i ich kombinacje do leczenia choroby dróg oddechowych u koni
CN111840256A (zh) * 2019-04-29 2020-10-30 上海谷森医药有限公司 一种雾化吸入剂及其制备方法
US11642333B2 (en) 2019-05-23 2023-05-09 Anovent Pharmaceutical (U.S.), Llc Inhalable formulation of a solution containing vilanterol trifenatate and umeclidinium bromide
WO2021262648A1 (en) * 2020-06-23 2021-12-30 Anovent Pharmaceutical (U.S.), Llc Preparation of a pharmaceutical composition of olodaterol and budesonide
CN115989032A (zh) 2020-07-31 2023-04-18 化学研究有限公司 用于吸入施用的组合疗法
US11844793B2 (en) 2020-09-29 2023-12-19 Aerorx Therapeutics Llc Liquid formulations of indacaterol

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954049A (en) 1991-10-15 1999-09-21 Trudell Medical Limited Equine mask with MDI adapter
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US5823179A (en) * 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6264923B1 (en) 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6904908B2 (en) * 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
DE10237739A1 (de) * 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
US20040053902A1 (en) * 2002-09-13 2004-03-18 Smith C. Steven Novel composition and method for treatment of upper respiratory conditions
CA2525943A1 (en) 2003-05-22 2004-12-02 Altana Pharma Ag Salmeterol and ciclesonide combination
US20050020692A1 (en) * 2003-07-24 2005-01-27 Ciofalo Vincent B. Treatment of heaves
EP1670482B2 (en) 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
JP2007533706A (ja) 2004-04-20 2007-11-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用
WO2006003078A1 (en) 2004-06-29 2006-01-12 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising steroids and an anticholinergic
DE102004056579A1 (de) * 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
US20070028923A1 (en) 2005-08-08 2007-02-08 Patrick Souris Tip-laryngeal airway
UY30542A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
UY30543A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
PL2346625T5 (pl) 2008-10-30 2024-04-29 Primetals Technologies Germany Gmbh Sposób nastawiania grubości wylotowej materiału walcowanego przebiegającego przez wieloklatkowy zespół walcowniczy, urządzenie sterujące i/lub regulujące oraz instalacja walcownicza
US8815258B2 (en) * 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
EP2445558B1 (en) * 2009-06-25 2016-06-29 Boehringer Ingelheim Vetmedica GmbH Inhaler
WO2014007767A1 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose and a ternary component
WO2014007766A1 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose
WO2014016548A2 (en) * 2012-07-27 2014-01-30 Cipla Limited Pharmaceutical composition
US9539408B2 (en) * 2012-10-31 2017-01-10 Trudell Medical International Nebulizer apparatus
LT3473255T (lt) * 2012-12-21 2022-03-10 Boehringer Ingelheim Vetmedica Gmbh Farmacinė vaisto forma, apimanti ciklezonidą
WO2014096115A1 (en) 2012-12-21 2014-06-26 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for the treatment of airway disease in horses
EP3035886B1 (en) * 2013-08-20 2020-10-07 Boehringer Ingelheim Vetmedica GmbH Inhaler
BR112016000367B1 (pt) * 2013-08-20 2021-12-28 Boehringer Ingelheim Vetmedica Gmbh Inalador, preferencialmente para inserção em uma narina
PL3157522T3 (pl) 2014-06-18 2020-03-31 Boehringer Ingelheim Vetmedica Gmbh Antagonisty muskarynowi i ich kombinacje do leczenia choroby dróg oddechowych u koni

Also Published As

Publication number Publication date
KR20170016986A (ko) 2017-02-14
CY1122335T1 (el) 2021-01-27
US20190262329A1 (en) 2019-08-29
AU2020202402B2 (en) 2021-05-27
US9474747B2 (en) 2016-10-25
US20150366855A1 (en) 2015-12-24
HRP20192010T1 (hr) 2020-02-07
US10342789B2 (en) 2019-07-09
US20170007593A1 (en) 2017-01-12
KR102618119B1 (ko) 2023-12-27
PL3157522T3 (pl) 2020-03-31
EP3157522A1 (en) 2017-04-26
AU2015276310B2 (en) 2020-01-16
DK3157522T3 (da) 2019-12-09
CA2952701C (en) 2023-09-19
AU2020202402A1 (en) 2020-04-30
PT3157522T (pt) 2019-12-13
EP3603640A1 (en) 2020-02-05
SI3157522T1 (sl) 2020-01-31
AU2015276310A1 (en) 2016-12-08
ES2759247T3 (es) 2020-05-08
RS59613B1 (sr) 2020-01-31
CA2952701A1 (en) 2015-12-23
LT3157522T (lt) 2019-11-25
MX2016016720A (es) 2017-04-13
EP3157522B1 (en) 2019-09-04
MX370430B (es) 2019-12-13
HUE051527T2 (hu) 2021-03-01
US10682345B2 (en) 2020-06-16
WO2015193213A1 (en) 2015-12-23

Similar Documents

Publication Publication Date Title
MX2019014935A (es) Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos.
HK1246600B (zh) 使用動物飼料的寡糖組合物以及其製造方法
ZA201608077B (en) Combination, composition, and method of administering the combination or composition to animals
MX2021007268A (es) Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acetico, composiciones, y usos de las mismas.
SG10201903823QA (en) Methods and compositions relating to microbial treatment and diagnosis of disorders
EA201790528A1 (ru) Дигидропирролопиридиновые ингибиторы ror-гамма
EA201691988A1 (ru) Производные бороновой кислоты и их терапевтическое применение
PH12015502216A1 (en) Compositions and methods for improving the health of aquatic animals
EA201790273A1 (ru) Флагеллиновые композиции и их применение
WO2014151456A3 (en) Treatment of inflammatory diseases
MX2017009417A (es) Formas solidas de acido 2-(5-(3-fluorofenil)-3-hidroxipicolinamido )acetico, composiciones y usos de las mismas.
IN2015DN02894A (es)
EA201890449A1 (ru) Фумагиллиновые гетероциклические соединения и способы их получения и применения
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
WO2016011049A3 (en) Compositions and methods for disease treatment using nanoparticle delivered compounds
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
FR3022139B1 (fr) Nouvelles compositions pour le traitement des rougeurs cutanees et de la rosacee
MX2017001293A (es) Metodos y composiciones para diagnosticar y tratar trastornos inflamatorios del intestino.
WO2015003049A3 (en) Compositions and methods to treat inflammatory joint disease
WO2016083315A8 (en) Use of ox1r antagonists for the treatment of inflammatory bowel diseases
MX2017009452A (es) Agentes de imagenologia para tomografia de emision de positrones (pet).
AU2014353885A8 (en) Prevention and treatment of toxicosis
IN2013MU03429A (es)
MX2015012393A (es) Derivados oxindol con un sustituyente oxetano y uso de los mismos para tratar enfermedades relacionadas con la vasopresina.
UA108238C2 (xx) Антибактеріальна композиція